|
|
NCI Extramural Support
|
Extramural Support
|
$4,337,000
|
$4,337,000
|
NA
|
NCI (NCI)
|
|
|
Training Program in Cancer Biology
|
5T32CA078207-09
|
$377,072
|
$128,204
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Modeling androgen-independent prostate cancer in mutant mice
|
1R01CA115717-01A2
|
$293,554
|
$293,554
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Roles of Nkx3.1 in prostate development and cancer
|
5R01CA076501-10
|
$311,841
|
$311,841
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
A Mouse Model for Prostate Cancer
|
5U01CA084294-09
|
$1,212,233
|
$1,212,233
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
1R01CA123484-01A2
|
$291,406
|
$291,406
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
Modulation of Androgen Signaling in Prostate Cancer
|
5R01CA104910-05
|
$297,965
|
$297,965
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-09
|
$645,635
|
$225,972
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
|
5U54CA091431-07
|
$1,410,542
|
$423,163
|
ADAMS-CAMPBELL, LUCILE
|
HOWARD UNIVERSITY
|
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-04
|
$281,848
|
$281,848
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed
|
5R01CA091883-05
|
$322,524
|
$322,524
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
|
Functional analysis of signaling to and from p53 in ca
|
5R01CA098916-06
|
$258,227
|
$51,645
|
AGARWAL, Munna
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Prostate cancer prevention and treatment by sillibinin
|
5R01CA102514-05
|
$322,762
|
$322,762
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
|
Cancer Chemoprevention by IP6: Efficacy and Mechanism
|
5R01CA116636-02
|
$261,552
|
$261,552
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
1R21CA118362-01A1
|
$180,000
|
$180,000
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
1R44CA124032-01A1
|
$101,130
|
$101,130
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-02
|
$250,774
|
$250,774
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Phase III Trial of Selenium for Prostate Cancer Prevention
|
5R01CA077789-09
|
$605,351
|
$605,351
|
Ahmann, Frederick
|
UNIVERSITY OF ARIZONA
|
|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-32
|
$215,048
|
$215,048
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$2,342
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$194,262
|
Alavanja
|
DCEG (NCI)
|
|
|
Studies of Alpha-tocopherol and Beta-Carotene in Finland
|
Z01 CP010195
|
$742,362
|
$194,492
|
Albanes
|
DCEG (NCI)
|
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
1R01CA129003-01A1
|
$291,650
|
$291,650
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-08
|
$651,256
|
$130,251
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$29,065
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$9,058
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$26,231
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$7,054
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$329,952
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-08
|
$511,051
|
$102,210
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-03S1
|
$64,761
|
$16,190
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-03
|
$471,027
|
$117,757
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Cancer Information Service
|
N02CO511003-003
|
$933,772
|
$102,715
|
ALBRECHT, TERRANCE
|
Wayne State University
|
|
|
Characterization of WWOX, the Ca. Gene Spanning FREA16D
|
5R01CA102444-05
|
$318,565
|
$63,713
|
ALDAZ, C. MARCELO
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-22
|
$311,649
|
$77,912
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Deformable registration for image-guided radiotherapy
|
1F32CA124138-01A1
|
$44,846
|
$44,846
|
Alterovitz, Ron
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Control of apoptosis in cancer by survivin
|
5R01CA078810-11
|
$283,430
|
$93,532
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-08
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Maryland Prostate Cancer Case-Control Study
|
Z01 BC 010499
|
$369,832
|
$369,832
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
Z01 BC 010624
|
$369,832
|
$369,832
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in Smokers
|
Z01 BC 010660
|
$184,916
|
$184,916
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$722,377
|
$108,357
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
$23,652
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$12,880
|
Anderson
|
DCEG (NCI)
|
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-085
|
$1,656,966
|
$414,242
|
ANDRIOLE, GERALD
|
THE WASHINGTON UNIVERSITY
|
|
|
Extension of Radiotherapy Research
|
5P01CA006294-43
|
$1,506,020
|
$150,602
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Mammalian Target of Rapamycin in Prostate Carcinogenesis
|
5R01CA101012-05
|
$562,905
|
$562,905
|
ARBEIT, JEFFREY
|
WASHINGTON UNIVERSITY
|
|
|
African American Men Prostate & Colorectal Cancer Belief
|
5R21CA113943-02
|
$125,532
|
$62,766
|
ARCURY, THOMAS
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Vaccine Clinical Trials
|
Z01 BC 010662
|
$666,536
|
$266,614
|
Arlen, Philip
|
CCR (NCI)
|
|
|
MR Imaging of Endothelial Progenitor Cells in Prostate Cancer
|
5R21CA122515-02
|
$181,538
|
$181,538
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Total relevant funding to Prostate for this search: $296,066,348
|
